AlphAIalphai — Financial news for AI agents
investing.comAUG 184 min read$DCGO

Why is DocGo stock tumbling today?

DocGo (DCGO) shares fell 12.7% pre-open to $0.62 after its Q2 2026 adjusted loss was $0.16 per share versus $0.10 consensus. Revenue was $73.4M, below $75.4M forecast and down 8.7% YoY, tied to wind-down of migrant contracts. It widened FY2026 adjusted EBITDA loss to $17M-$22M and agreed to acquire Hicuity Health (~$65M trailing revenue).

Original reporting
investing.com
Published Aug 18, 2026, 9:07 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:26 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$DCGO
Bearish
high confidence
Mentioned
$DCGO
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$DCGOBearishHigh
01

Why it matters

Traders are repricing DCGO based on a Q2 earnings miss, a sharply widened full-year adjusted EBITDA loss range, and added uncertainty from a definitive acquisition agreement plus an SEC 10-Q filing extension request.

02

Market read

A same-day combination of earnings miss, materially worse guidance, and acquisition/integration and filing uncertainty is a high-conviction catalyst for DCGO’s near-term trading.

03

What to watch

The acquisition of Hicuity Health could offset some revenue softness if integration succeeds, and the SEC 10-Q extension may be procedural rather than signaling deeper issues.

Relevance 9/10Novelty 9/10Timing: pre-open today, stock down 12.7% in pre-market on the new earnings, guidance, and acquisition disclosures

Background

DocGo is a mobile health and medical transportation company facing contract wind-downs and ongoing profitability challenges.

Company-level read

Ticker impact

$DCGOBearishHigh confidence
Context

DocGo reported Q2 2026 adjusted loss of $0.16 vs $0.10 consensus, revenue $73.4M vs $75.4M, and widened full-year adjusted EBITDA loss guidance to $17M-$22M.

Expected impact

Bearish near-term as guidance deterioration and integration/filing uncertainty likely keep downside pressure until clarity on acquisition and SEC filing timing.

Evidence & confidence

The article cites multiple same-day fundamentals for DCGO: Q2 miss, guidance widening more than double prior range, acquisition agreement introducing integration risk, and a requested SEC 10-Q filing extension.

Market effects

Sector

Weakens sentiment for mobile health and medical transportation providers by highlighting contract wind-down risk and profitability delays.

Regional

Primarily US micro-cap risk appetite, with broader index weakness amplifying the move.

Global

Limited direct global spillover; the story is company-specific with macro backdrop only.

Counterpoint

What could challenge this read

Core revenue excluding migrant-related programs grew 19%, so the market may be over-penalizing one-time contract wind-down versus underlying demand.

Key entities

  • public_company
    DocGo

    Mobile health and medical transportation provider whose Q2 results, guidance, and acquisition agreement drove the pre-market selloff.

  • public_or_private_company
    Hicuity Health

    Telemedicine provider DocGo agreed to acquire, adding integration risk at a strained balance sheet.

  • regulator
    SEC

    DocGo requested a brief extension to file its quarterly Form 10-Q.

Read at source← All news

Also covered by

2 outlets

Related articles

AUG 20
Med

DocGo Inc. Q2 2026 Earnings Call Summary

DocGo Inc. reported Q2 2026 earnings, highlighting a 19% year-over-year revenue increase in core business lines, despite a $6.3M adjusted EBITDA loss. The company announced its largest acquisition, Hicuity Health, aiming to integrate hospital and home care. Management expects to achieve positive adjusted EBITDA by year-end 2026, with revenue guidance narrowed to $305M-$310M. Cost synergies and efficiency programs are expected to drive future growth.

yahoo.com2 min
AUG 19
$DCGOMed

DocGo Shares Tumble After Earnings Miss and Wider Loss Forecast

DocGo (DCGO) shares fell 12.7% pre-market Tuesday after Q2 2026 earnings missed estimates, with a $0.16 loss per share vs. expected $0.10. Revenue was $73.4M, down 8.7% YoY, and the company widened its full-year adjusted EBITDA loss forecast to $17M-$22M. The decline followed the end of migrant-related contracts, though core revenue grew 19%. The stock trades near its 52-week low of $0.451.

yahoo.com2 min
AUG 19
$DCGOMed

DocGo Q2 Earnings Call Highlights

DocGo reported record service volumes in Q2, with year-over-year growth across all core businesses. The company acquired Hicuity, assuming $52M in debt and issuing 2% equity. DocGo's revenue rose to $52M in medical transportation but fell in mobile health due to migrant-related work decline. Adjusted EBITDA loss narrowed to $6.3M. The company updated its full-year outlook, expecting a wider EBITDA loss of $17M-$22M. DocGo has $48.1M in cash and expects positive adjusted EBITDA run rate by year-e

yahoo.com3 min
AUG 19
$DCGOMed

DocGo Inc (DCGO) (Q2 2026) Earnings Call Highlights: Record Volumes and Strategic

DocGo Inc (DCGO) reported Q2 2026 revenue of $73.4M, down from $80.4M YoY, and widened its adjusted EBITDA loss guidance to $17M-$22M. Gross margins declined due to lower margins in the Mobile Health segment and higher fuel costs. The company's cash position decreased to $48.1M. The Hicuity acquisition faces regulatory and customer approval hurdles. Organic revenue grew approximately 5% YoY. The company aims to achieve adjusted EBITDA breakeven by the end of 2026 through revenue growth, improved

yahoo.com7 min
AUG 18
$DCGOHighAI 9/10

Why is DocGo stock sliding today?

DocGo (DCGO) shares fell about 12.7% pre-open to $0.62 after its Q2 2026 results missed expectations. Adjusted loss per share was $0.16 vs $0.10 forecast, revenue was $73.4M vs $75.4M. DocGo cut full-year 2026 adjusted EBITDA guidance to a $17M to $22M loss and agreed to acquire Hicuity Health, largely via debt assumption and new financing.

investing.com4 min